Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2025-12-24 @ 4:39 PM
NCT ID:
NCT04678466
Eligibility Criteria:
Inclusion Criteria:
* Weight of at least 17 kilograms
* CD123-positive hematologic malignancy
* Adequate organ reserve
* Provider and site are trained on study protocol using flotetuzumab
Exclusion Criteria:
* AML that meets inclusion criteria for study CP-MGD006-01 (NCT02152956)
* Primary induction failure
* Early relapse (less than 6 months after first complete remission )
* Three prior lines of therapy, including maximum of 1 prior salvage attempts
Sex:
ALL
Study:
NCT04678466
Study Brief:
Protocol Section:
NCT04678466